Identification of Extremely Rare Pathogenic CNVs by Array CGH in Saudi Children with Developmental Delay, Congenital Malformations, and Intellectual Disability

Chromosomal imbalance is implicated in developmental delay (DD), congenital malformations (CM), and intellectual disability (ID), and, thus, precise identification of copy number variations (CNVs) is essential. We therefore aimed to investigate the genetic heterogeneity in Saudi children with DD/CM/ID. High-resolution array comparative genomic hybridization (array CGH) was used to detect disease-associated CNVs in 63 patients. Quantitative PCR was done to confirm the detected CNVs. Giemsa banding-based karyotyping was also performed. Array CGH identified chromosomal abnormalities in 24 patients; distinct pathogenic and/or variants of uncertain significance CNVs were found in 19 patients, and aneuploidy was found in 5 patients including 47,XXY (n = 2), 45,X (n = 2) and a patient with trisomy 18 who carried a balanced Robertsonian translocation. CNVs including 9p24p13, 16p13p11, 18p11 had gains/duplications and CNVs, including 3p23p14, 10q26, 11p15, 11q24q25, 13q21.1q32.1, 16p13.3p11.2, and 20q11.1q13.2, had losses/deletions only, while CNVs including 8q24, 11q12, 15q25q26, 16q21q23, and 22q11q13 were found with both gains or losses in different individuals. In contrast, standard karyotyping detected chromosomal abnormalities in ten patients. The diagnosis rate of array CGH (28%, 18/63 patients) was around two-fold higher than that of conventional karyotyping (15.87%, 10/63 patients). We herein report, for the first time, the extremely rare pathogenic CNVs in Saudi children with DD/CM/ID. The reported prevalence of CNVs in Saudi Arabia adds value to clinical cytogenetics.

[1]  I. Mills,et al.  Spatially resolved clonal copy number alterations in benign and malignant tissue , 2022, Nature.

[2]  C. V. van Asperen,et al.  Recommendations for reporting results of diagnostic genomic testing , 2022, European Journal of Human Genetics.

[3]  S. Hassan,et al.  Consanguinity and Congenital Heart Disease Susceptibility: Insights into Rare Genetic Variations in Saudi Arabia , 2022, Genes.

[4]  Bernat Gel,et al.  Evaluation of CNV detection tools for NGS panel data in genetic diagnostics , 2020, European Journal of Human Genetics.

[5]  J. Merrick,et al.  A clinical primer on intellectual disability , 2020, Translational pediatrics.

[6]  S. South,et al.  Technical standards for the interpretation and reporting of constitutional copy number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen) , 2019, Genetics in Medicine.

[7]  T. Liehr,et al.  DNA Copy Number Variations as Markers of Mutagenic Impact , 2019, International journal of molecular sciences.

[8]  Le Zhang,et al.  Correction: Comprehensively benchmarking applications for detecting copy number variation , 2019, PLoS Comput. Biol..

[9]  Chih-ping Chen,et al.  Array-CGH increased the diagnostic rate of developmental delay or intellectual disability in Taiwan. , 2019, Pediatrics and neonatology.

[10]  Peter Natesan Pushparaj,et al.  Array comparative genomic hybridization based identification of key genetic alterations at 2p21-p16.3 (MSH2, MSH6, EPCAM), 3p23-p14.2 (MLH1), 7p22.1 (PMS2) and 1p34.1-p33 (MUTYH) regions in hereditary non polyposis colorectal cancer (Lynch syndrome) in the Kingdom of Saudi Arabia , 2019, Saudi journal of biological sciences.

[11]  Le Zhang,et al.  Comprehensively benchmarking applications for detecting copy number variation , 2019, PLoS Comput. Biol..

[12]  Steven P. Miller,et al.  Practice parameter: neuroimaging of the neonate: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. , 2019, Neurology.

[13]  K. Sullivan Chromosome 22q11.2 deletion syndrome and DiGeorge syndrome , 2019, Immunological reviews.

[14]  Peter Natesan Pushparaj,et al.  Genomic amplification of chromosome 7 in the Doxorubicin resistant K562 cell line , 2018, Bioinformation.

[15]  M. Yasir,et al.  Detection of genetic alterations in gastric cancer patients from Saudi Arabia using comparative genomic hybridization (CGH) , 2018, PloS one.

[16]  A. Chaudhary,et al.  Identification of De Novo and Rare Inherited Copy Number Variants in Children with Syndromic Congenital Heart Defects , 2018, Pediatric Cardiology.

[17]  M. Assidi,et al.  Use of Array Comparative Genomic Hybridization for the Diagnosis of DiGeorge Syndrome in Saudi Arabian Population , 2018, Cytogenetic and Genome Research.

[18]  Biren M. Dave,et al.  OTUD7A Regulates Neurodevelopmental Phenotypes in the 15q13.3 Microdeletion Syndrome , 2018, American journal of human genetics.

[19]  R. Hennekam,et al.  Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement , 2018, Nature Reviews Endocrinology.

[20]  Peter Natesan Pushparaj,et al.  Chromosomal Micro-aberration in a Saudi Family with Juvenile Myoclonic Epilepsy. , 2017, CNS & neurological disorders drug targets.

[21]  E. McCann,et al.  Current evidence-based recommendations on investigating children with global developmental delay , 2017, Archives of Disease in Childhood.

[22]  Sajjad Karim,et al.  Genomic answers for recurrent spontaneous abortion in Saudi Arabia: An array comparative genomic hybridization approach. , 2017, Reproductive biology.

[23]  Bradley P. Coe,et al.  Targeted sequencing identifies 91 neurodevelopmental disorder risk genes with autism and developmental disability biases , 2017, Nature Genetics.

[24]  D. Pilz,et al.  Clinical features associated with CTNNB1 de novo loss of function mutations in ten individuals. , 2017, European journal of medical genetics.

[25]  A. Chaudhary,et al.  Genome wide array-CGH and qPCR analysis for the identification of genome defects in Williams’ syndrome patients in Saudi Arabia , 2016, Molecular Cytogenetics.

[26]  C. Powell,et al.  Survival of children with trisomy 13 and trisomy 18: A multi‐state population‐based study , 2016, American journal of medical genetics. Part A.

[27]  S. Mattson,et al.  Jacobsen syndrome: Advances in our knowledge of phenotype and genotype , 2015, American journal of medical genetics. Part C, Seminars in medical genetics.

[28]  M. Adam,et al.  Evaluation and diagnosis of the dysmorphic infant. , 2015, Clinics in perinatology.

[29]  E. Guillén-Navarro,et al.  Clinical comparison of 10q26 overlapping deletions: Delineating the critical region for urogenital anomalies , 2015, American journal of medical genetics. Part A.

[30]  M. I. Melaragno,et al.  Duplication 9p and their implication to phenotype , 2014, BMC Medical Genetics.

[31]  M. Waldenberger,et al.  Compound heterozygosity of low-frequency promoter deletions and rare loss-of-function mutations in TXNL4A causes Burn-McKeown syndrome. , 2014, American journal of human genetics.

[32]  E. Goldmuntz,et al.  22q11.2 Deletion syndrome is associated with increased perioperative events and more complicated postoperative course in infants undergoing infant operative correction of truncus arteriosus communis or interrupted aortic arch. , 2014, The Journal of thoracic and cardiovascular surgery.

[33]  J. Moeschler,et al.  Comprehensive Evaluation of the Child With Intellectual Disability or Global Developmental Delays , 2014, Pediatrics.

[34]  M. Ninan,et al.  Durable Hematological and Major Cytogenetic Response in a Patient with Isolated 20q Deletion Myelodysplastic Syndrome Treated with Lenalidomide , 2014, Case reports in oncological medicine.

[35]  David T. Miller,et al.  Chromosomal microarray impacts clinical management , 2014, Clinical genetics.

[36]  N. Brown,et al.  Characterization of core clinical phenotypes associated with recurrent proximal 15q25.2 microdeletions , 2014, American journal of medical genetics. Part A.

[37]  Sang-Jin Park,et al.  The clinical application of array CGH for the detection of chromosomal defects in 20,126 unselected newborns , 2013, Molecular Cytogenetics.

[38]  Yu-ping Wang,et al.  Comparative Studies of Copy Number Variation Detection Methods for Next-Generation Sequencing Technologies , 2013, PloS one.

[39]  M. Tzetis,et al.  Array comparative genomic hybridization as a clinical diagnostic tool in syndromic and nonsyndromic congenital heart disease , 2013, Pediatric Research.

[40]  P. Stankiewicz,et al.  Comparison of chromosome analysis and chromosomal microarray analysis: what is the value of chromosome analysis in today’s genomic array era? , 2012, Genetics in Medicine.

[41]  Marc S. Williams,et al.  Clinical Utility of Chromosomal Microarray Analysis , 2012, Pediatrics.

[42]  B. Rodríguez-Santiago,et al.  Contribution of Rare Copy Number Variants to Isolated Human Malformations , 2012, PloS one.

[43]  Bradley P. Coe,et al.  Genome structural variation discovery and genotyping , 2011, Nature Reviews Genetics.

[44]  D. Ledbetter,et al.  Adaptor protein complex-4 (AP-4) deficiency causes a novel autosomal recessive cerebral palsy syndrome with microcephaly and intellectual disability , 2010, Journal of Medical Genetics.

[45]  Leslie G Biesecker,et al.  Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. , 2010, American journal of human genetics.

[46]  Tomas W. Fitzgerald,et al.  Origins and functional impact of copy number variation in the human genome , 2010, Nature.

[47]  A. Rauch,et al.  Comprehensive genotype–phenotype analysis in 230 patients with tetralogy of Fallot , 2009, Journal of Medical Genetics.

[48]  P. Stankiewicz,et al.  Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size , 2009, Journal of Medical Genetics.

[49]  Frank Speleman,et al.  Challenges for CNV interpretation in clinical molecular karyotyping: lessons learned from a 1001 sample experience. , 2009, European journal of medical genetics.

[50]  N. de Leeuw,et al.  An 8.35 Mb overlapping interstitial deletion of 8q24 in two patients with coloboma, congenital heart defect, limb abnormalities, psychomotor retardation and convulsions. , 2009, European journal of medical genetics.

[51]  U. Pannicke,et al.  Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II , 2009, Nature Genetics.

[52]  P. Stankiewicz,et al.  Clinical and molecular‐cytogenetic evaluation of a family with partial Jacobsen syndrome without thrombocytopenia caused by an ∼5 Mb deletion del(11)(q24.3) , 2008, American journal of medical genetics. Part A.

[53]  D. Hernandez,et al.  A duplication at chromosome 11q12.2–11q12.3 is associated with spinocerebellar ataxia type 20 , 2008, Human molecular genetics.

[54]  J. D. den Dunnen,et al.  Successful long-term growth hormone therapy in a girl with haploinsufficiency of the insulin-like growth factor-I receptor due to a terminal 15q26.2->qter deletion detected by multiplex ligation probe amplification. , 2008, The Journal of clinical endocrinology and metabolism.

[55]  N. Fida,et al.  A prospective study of congenital malformations among live born neonates at a University Hospital in Western Saudi Arabia. , 2007, Saudi medical journal.

[56]  N. Niikawa,et al.  CHMP4B, a novel gene for autosomal dominant cataracts linked to chromosome 20q. , 2007, American journal of human genetics.

[57]  N. Carter Methods and strategies for analyzing copy number variation using DNA microarrays , 2007, Nature Genetics.

[58]  D. Conrad,et al.  Global variation in copy number in the human genome , 2006, Nature.

[59]  A. Dutra,et al.  Core binding factor beta (CBFB) haploinsufficiency due to an interstitial deletion at 16q21q22 resulting in delayed cranial ossification, cleft palate, congenital heart anomalies, and feeding difficulties but favorable outcome , 2006, American journal of medical genetics. Part A.

[60]  Y. Fukushima,et al.  Large fontanelles are a shared feature of haploinsufficiency of RUNX2 and its co‐activator CBFB , 2004, Congenital anomalies.

[61]  M A Whelen,et al.  Practice parameter: Evaluation of the child with global developmental delay , 2003, Neurology.

[62]  S. Minoshima,et al.  Role of TBX1 in human del22q11.2 syndrome , 2003, The Lancet.

[63]  M. Gingold,et al.  CME Practice parameter : Evaluation of the child with global developmental delay , 2003 .